$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Process for covalent coupling for the production of conjugates, and polysaccharide containing products thereby obtained 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C08B-037/08
  • C08B-037/10
출원번호 US-0464996 (1983-02-08)
우선권정보 SE-0000751 (1982-02-09)
발명자 / 주소
  • Larm Olle (Nyngsvgen 86 S-161 39 Bromma SEX)
인용정보 피인용 횟수 : 130  인용 특허 : 5

초록

A process to produce by covalent binding conjugates of a substance containing a 2-amino-2-deoxyglycopyranosyl residue the NH2-function of which in its most stable conformation is equatorially oriented, and a substrate containing a primary amino group. This is done by subjecting the substance to degr

대표청구항

A conjugate comprising a 1-deoxy-2,5-anhydrohexitol unit which constitutes the terminal unit in a substance selected from the group consisting of heparin, deacetylated dermatan sulfate, chitosan, and deacetylated hyaluronic acid, which substance is covalently bound in the 1-position to an amino grou

이 특허에 인용된 특허 (5)

  1. Koshugi Junichi (Tokyo JPX), Chitin containing poly-ion complex.
  2. Hall Laurance D. (Vancouver CAX) Yalpani Mansur (Vancouver CAX), Derivatives of chitins, chitosans and other polysaccharides.
  3. Joh Yasushi (Yokohama JPX), Non-thrombogenic material comprising substrate which has been reacted with heparin.
  4. Eriksson ; Jan-Christer ; Larsson ; Rolf ; Rosengren ; Ake ; Hjelte ; Ma j-Britt, Non-thrombogenic medical article and a method for its preparation.
  5. Cuatrecasas Pedro (10 Hillside Road Baltimore MD 21210) Parikh Indu (4404 Keswick Road Baltimore MD 21210), Polysaccharide matrices for use as adsorbents in affinity chromatography techniques.

이 특허를 인용한 특허 (130)

  1. Hans-Arne Hansson SE; Gunilla Johansson-Ruden SE; Olle Larm SE, Agents, and methods employing them, for the prevention or reduction of tissue adhesion at a wound site.
  2. Falotico, Robert; Kopia, Gregory A.; Llanos, Gerard H.; Siekierka, John; Carter, Andrew J., Antiinflammatory drug and delivery device.
  3. Larsson Kare V. (Bjrred) Bergentz Sven E. (Malm) Lindblad Bengt L. T. (Malm SEX), Antithrombogenic article containing lysozyme and heparin adsorbed on a substrate.
  4. Cahalan Linda L. (Geleen NLX) Cahalan Patrick T. (Geleen NLX) Verhoeven Michel (Maastricht NLX) Hendriks Marc (Hoensbroek NLX) Fouache Benedicte (Maastricht NLX), Biocompatible medical article and method.
  5. Cahalan Linda L.,NLX ; Cahalan Patrick T.,NLX ; Verhoeven Michel,NLX ; Hendriks Marc,NLX ; Fouache Benedicte,NLX, Biocompatible medical article and method.
  6. Nelson Deanna J. ; Hai Ton That ; Pereira David E. ; Estep Timothy N., Biocompatible surfaces and a method for their preparation.
  7. Sheu Min-Shyan ; Loh Ih-Houng, Biomedical articles with ionically bonded polyelectrolyte coatings.
  8. Tuch Ronald J., Blood contacting medical device and method.
  9. Tuch Ronald J., Blood-contacting medical device and method.
  10. Lentz, David Christian; Llanos, Gerard H.; Roller, Mark B.; Scopelianos, Angelo; Weadock, Kevin, Coated medical devices.
  11. Falotico,Robert; Spaltro,John, Coated medical devices for the treatment of vulnerable plaque.
  12. Antoni, Per; Nystrom, Daniel; Vincent, Lars; Pietrzak, Krzysztof, Coating for substrate.
  13. Sakiyama-Elbert, Shelly E.; Hubbell, Jeffrey A., Controlled release of non heparin-binding growth factors from heparin-containing matrices.
  14. Marburg Stephen (Metuchen NJ) Tolman Richard L. (Warren NJ) Jorn Deborah A. (Metuchen NJ), Covalently-modified neutral bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogeni.
  15. Larm, Olle; Bergstrom, Tomas; Axelsson, Jonas; Adolfsson, Lars; Ward, Robert S.; McCrae, Keith, Device and method for restoration of the condition of blood.
  16. Larm, Olle; Bergström, Tomas; Axelsson, Jonas; Adolfsson, Lars; Ward, Robert S.; McCrea, Keith, Device and method for restoration of the condition of blood.
  17. Ding Ni ; Helmus Michael N., Drug coating with topcoat.
  18. Ding Ni ; Helmus Michael N., Drug coating with topcoat.
  19. Ding, Ni; Helmus, Michael N., Drug coating with topcoat.
  20. Hsu, Li-Chien, Drug eluting coatings for medical implants.
  21. Hsu,Li Chien, Drug eluting coatings for medical implants.
  22. Hsu, Li-Chien, Drug eluting coatings for medical implants and methods of use.
  23. Ni Ding ; Michael N. Helmus, Drug release stent coating.
  24. Ding Ni ; Helmus Michael N., Drug release stent coating process.
  25. Evens,Carl J.; Weedock,Kevin, Drug releasing anastomosis devices and methods for treating anastomotic sites.
  26. Ding Ni ; Raeder-Devens Jennifer E. ; Trinh Tuyethoa Thi, Drug-releasing coatings for medical devices.
  27. Ding Ni ; Raeder-Devens Jennifer E. ; Trinh Tuyethoa Thi, Drug-releasing coatings for medical devices.
  28. Falotico, Robert; Siekierka, John; Llanos, Gerard H.; Kopia, Gregory A.; Carter, Andrew J., Drug/drug delivery systems for the prevention and treatment of vascular disease.
  29. Falotico,Robert; Kopia,Gregory A.; Llanos,Gerard H., Drug/drug delivery systems for the prevention and treatment of vascular disease.
  30. Hubbell Jeffrey A.,CHX ; Schense Jason,CHX, Enzyme-mediated modification of fibrin for tissue engineering.
  31. Hubbell,Jeffrey A.; Schense,Jason C.; Sakiyama,Shelly E., Enzyme-mediated modification of fibrin for tissue engineering: fibrin formulations with peptides.
  32. Hubbell, Jeffrey A.; Schense, Jason C.; Sakiyama, Shelly E., Enzyme-mediated modification of fibrin for tissue engineering: incorporation of proteins.
  33. Hubbell, Jeffrey A.; Schense, Jason, Enzyme-mediated modification of fivrin for tissue engineering.
  34. della Valle Francesco (Padova ITX) Romeo Aurelio (Rome ITX), Esters of hyaluronic acid.
  35. Berry, Leslie; Andrew, Maureen, Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates.
  36. Hubbell, Jeffrey A.; Schense, Jason C.; Sakiyama Elbert, Shelly E., Growth factor modified protein matrices for tissue engineering.
  37. Hubbell, Jeffrey A.; Schense, Jason C.; Sakiyama-Elbert, Shelly E., Growth factor modified protein matrices for tissue engineering.
  38. L?tolf,Matthias; Schense,Jason; Hubbell,Jeffrey A.; Jen,Anna, Growth factor modified protein matrices for tissue engineering.
  39. Llanos, Gerard H.; Narayanan, Pallassana V.; Papandreou, George, Heparin barrier coating for controlled drug release.
  40. Koulik, Edouard, Heparin compositions and methods of making and using the same.
  41. Koulik, Edouard, Heparin compositions and methods of making and using the same.
  42. Cleek, Robert L.; Drumheller, Paul D; Li, Mei; Mardirosian, Nora, Heparin entities and methods of use.
  43. Marciani,Dante J., Imine-forming polysaccharide adjuvants and immunostimulants.
  44. Leontein, Karin; Antoni, Per; Nyström, Daniel; Begovac, Paul; Pietrzak, Krzysztof, Immobilised biological entities.
  45. Leontein, Karin; Antoni, Per; Nyström, Daniel; Begovac, Paul; Pietrzak, Krzysztof, Immobilised biological entities.
  46. Leontein, Karin; Antoni, Per; Nyström, Daniel; Begovac, Paul; Pietrzak, Krzysztof, Immobilised biological entities.
  47. Oscarson, Stefan; Lahmann, Martina; Leontein, Karin; Vestberg, Robert, Immobilised biological entities.
  48. Vestberg, Robert, Immobilised biological entities.
  49. Vestberg, Robert, Immobilised biological entities.
  50. Cleek, Robert L.; Daly, Michael D.; Pietrzak, Krzysztof R., Immobilized biologically active entities containing heparin having high biological activity following mechanical manipulation.
  51. Cleek, Robert L.; Daly, Michael D.; Pietrzak, Krzysztof R., Immobilized biologically active entities having a high degree of biological activity.
  52. Cleek, Robert L.; Daly, Michael D.; Pietrzak, Krzysztof R., Immobilized biologically active entities having a high degree of biological activity.
  53. Cleek, Robert L.; Daly, Michael D.; Pietrzak, Krzysztof R., Immobilized biologically active entities having a high degree of biological activity.
  54. Cleek, Robert L.; Daly, Michael D.; Pietrzak, Krzysztof R., Immobilized biologically active entities having a high degree of biological activity following sterilization.
  55. Cleek, Robert L.; Daly, Michael D.; Pietrzak, Krzysztof R., Immobilized biologically active entities having high biological activity following mechanical manipulation.
  56. Cleek, Robert L.; Daly, Michael D.; Pietrzak, Krzysztof R., Immobilized biologically active entities having high biological activity following mechanical manipulation.
  57. Soykan Orhan ; Donovan Maura G., Implantable system with drug-eluting cells for on-demand local drug delivery.
  58. Keogh James R., Ionic attachment of biomolecules with a guanidino moiety to medical device surfaces.
  59. Falotico,Robert; Llanos,Gerard H., Local delivery of rapamycin for treatment of proliferative sequelae associated with PTCA procedures, including delivery using a modified stent.
  60. Falotico,Robert; Llanos,Gerard H., Local delivery of rapamycin for treatment of proliferative sequelae associated with PTCA procedures, including delivery using a modified stent.
  61. Wright,Carol; Llanos,Gerard H.; Rakos,Ronald; King,Kristin; Falotico,Robert, Local delivery of rapamycin for treatment of proliferative sequelae associated with PTCA procedures, including delivery using a modified stent.
  62. Llanos,Gerard H.; Lentz,David Christian, Local drug delivery devices and methods for maintaining the drug coatings thereon.
  63. Schense, Jason; Watson, John; Arrighi, Isabelle, Local treatment of bone defects.
  64. Li-Chien Hsu ; Can B. Hu, Lubricious coatings for medical devices.
  65. Cleek, Robert L.; Daly, Michael D.; Pietrzak, Krzysztof R., Medical device capable of being compacted and expanded having anti-thrombin III binding activity.
  66. Leslie Berry CA; Maureen Andrew CA, Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates.
  67. Tuch,Ronald J., Medical device for delivering a therapeutic agent and method of preparation.
  68. Berg Eric P. ; Dinh Thomas Q., Medical device for delivering a therapeutic substance and method therefor.
  69. Berg, Eric P.; Dinh, Thomas Q., Medical device for delivering a therapeutic substance and method therefor.
  70. Thomas Q. Dinh ; Rodney G. Wolff ; Eric P. Berg, Medical device for delivering a therapeutic substance and method therefor.
  71. Dinh Thomas Q. ; Wolff Rodney G. ; Berg Eric P., Medical device for delivering a water-insoluble therapeutic salt or substance.
  72. Berg Eric P. ; Dinh Thomas Q., Medical device for delivering localized radiation.
  73. Berg, Eric P.; Tuch, Ronald J.; Dror, Michael; Wolff, Rodney G., Medical devices for delivering a therapeutic agent and method of preparation.
  74. Berg,Eric P.; Tuch,Ronald J.; Dror,Michael; Wolff,Rodney G., Medical devices for delivering a therapeutic agent and method of preparation.
  75. Ding Ni ; Helmus Michael N., Medical devices with long term non-thrombogenic coatings.
  76. Davila,Luis A.; Lentz,David Christian; Llanos,Gerard H.; Mendez,Jorge Orlando; Narayanan,Pallassana V.; Pelton,Alan Roy; Roller,Mark B.; Scheidt,Karl K.; Scopelianos,Angelo George; Shaw, Jr.,William , Medical devices, drug coatings and methods for maintaining the drug coatings thereon.
  77. Aster Richard H. ; Visentin Gian, Method and kit for detecting heparin induced thrombocytopenia.
  78. Keogh James R., Method for covalent attachment of biomolecules to surfaces of medical devices.
  79. Larm, Olle; Bergström, Tomas, Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood.
  80. Larm, Olle; Bergstrom, Tomas, Method for extracorporeal removal of pathogenic microbe, an inflammatory cell or an inflammatory protein from blood.
  81. Larm, Olle; Bergstrom, Tomas, Method for extracorporeal removal of pathogenic microbe, an inflammatory cell or an inflammatory protein from blood.
  82. Bothe, Harald; Qiu, Yongxing; Hagmann, Peter, Method for making UV-absorbing ophthalmic lenses.
  83. Verhoeven Michel (Maastricht NLX) Cahalan Linda L. (Geleen NLX) Hendriks Marc (Hoensbroek NLX) Fouache Benedicte (Hoensbroek NLX) Cahalan Patrick T. (Geleen NLX), Method for making heparinized biomaterials.
  84. Ding Ni, Method of applying drug-release coatings.
  85. Larm, Olle; Gouda, Ibrahim, Method of covalent coupling.
  86. Moghaddam Manouchehr ; Visentin Gian ; Aster Richard H. ; Boldt Benjamin W., Method of detecting heparin-induced thrombocytopenia.
  87. Cahalan, Patrick; Cahalan, Linda; Johnson, Greg; Gartner, Mark, Method of treating the surface of a medical device with a biomolecule.
  88. Andrelczyk, Susan, Methods for detecting heparin/platelet factor 4 antibodies.
  89. Ward, Robert S.; McCrea, Keith R.; Larm, Olle; Adolfsson, Lars, Methods for removing cytokines from blood with surface immobilized polysaccharides.
  90. Ward, Robert S; McCrea, Keith R; Larm, Olle; Adolfsson, Lars, Methods for removing cytokines from blood with surface immobilized polysaccharides.
  91. Berry,Leslie Roy; O'Brodovich, legal representative,Hugh; Chan,Anthony Kam Chuen; Andrew, deceased,Maureen, Methods of coating a device using anti-thrombin heparin.
  92. Marciani, Dante J., Modified polysaccharide adjuvant-protein antigen conjugates, the preparation thereof and the use thereof.
  93. Keogh James R., Oxidative method for attachment of biomolecules to surfaces of medical devices.
  94. Keogh James R., Oxidative method for attachment of glycoproteins or glycopeptides to surfaces of medical devices.
  95. Keogh James R., Oxidative method for attachment of glycoproteins to surfaces of medical devices.
  96. Charier, Gaëlle; Müller-Maissen, Manuela; Jen, Anna, PDGF fusion proteins incorporated into fibrin foams.
  97. Lutolf, Matthias; Schense, Jason C.; Hubbell, Jeffrey A.; Jen, Anna, PTH containing cell growth matrix.
  98. Keogh James R., Periodate oxidative method for attachment and crosslinking of biomolecules to medical device surfaces.
  99. Keogh James R., Periodate oxidative method for attachment of biomolecules to medical device surfaces.
  100. Glauser, Thierry; Pacetti, Stephen Dirk; Hossainy, Syed Faiyaz Ahmed; Ding, Ni, Phosphoryl choline coating compositions.
  101. Kausch, Annemie Rehor; Cerritelli, Simona, Polymeric tissue sealant.
  102. Rehor, Annemie; Cerritelli, Simona, Polymeric tissue sealant.
  103. Larm Olle (Nyngsvgen 86 S-161 39 Bromma SEX), Process for covalent coupling for the production of conjugates, and products hereby obtained.
  104. Wirt David F. ; Sirvio Larry M., Process for modifying surfaces using the reaction product of a water-insoluble polymer and a polyalkylene imine.
  105. Cahalan, Patrick; Cahalan, Linda; Johnson, Greg; Gartner, Mark, Process for preparing a substrate coated with a biomolecule.
  106. Hai Ton That ; Pereira David E. ; Nelson Deanna J., Reagents for isotropic size enhancement of a peptide, protein, nucleotide or other substrate.
  107. Wirt David F. ; Sirvio Lary M., Removal of biologically active agents.
  108. Mlson Tomas (Uppsala SEX) Ahrgren Leif G. (rbyhus SEX) de Belder Anthony N. (Uppsala SEX), Shaped article and processes for its preparation.
  109. Qiu, Yongxing, Silicone hydrogel lens with a crosslinked hydrophilic coating.
  110. Qiu, Yongxing; Samuel, Newton T.; Pruitt, John Dallas; Kolluru, Chandana; Medina, Arturo N.; Winterton, Lynn Cook; Wu, Daqing; Qian, Xinming; Nelson, Jared, Silicone hydrogel lens with a crosslinked hydrophilic coating.
  111. Qiu, Yongxing; Samuel, Newton T.; Pruitt, John Dallas; Kolluru, Chandana; Medina, Arturo Norberto; Winterton, Lynn Cook; Wu, Daqing; Qian, Xinming; Nelson, Jared, Silicone hydrogel lens with a crosslinked hydrophilic coating.
  112. Qiu, Yongxing; Samuel, Newton T.; Pruitt, John Dallas; Kolluru, Chandana; Medina, Arturo Norberto; Winterton, Lynn Cook; Wu, Daqing; Qian, Xinming; Nelson, Jared, Silicone hydrogel lens with a crosslinked hydrophilic coating.
  113. Qiu, Yongxing; Samuel, Newton T.; Pruitt, John Dallas; Kolluru, Chandana; Medina, Arturo Norberto; Winterton, Lynn Cook; Wu, Daqing; Qian, Xinming; Nelson, Jared, Silicone hydrogel lens with a crosslinked hydrophilic coating.
  114. Qiu, Yongxing; Samuel, Newton T.; Pruitt, John Dallas; Kolluru, Chandana; Medina, Arturo Norberto; Winterton, Lynn Cook; Wu, Daqing; Qian, Xinming; Nelson, Jared, Silicone hydrogel lens with a crosslinked hydrophilic coating.
  115. Qiu, Yongxing; Pruitt, John Dallas; Thekveli, Sibichen J.; Tucker, Robert Carey; Nelson, Jared, Silicone hydrogel lenses with water-rich surfaces.
  116. Qiu, Yongxing; Pruitt, John Dallas; Thekveli, Sibichen J.; Tucker, Robert Carey; Nelson, Jared, Silicone hydrogel lenses with water-rich surfaces.
  117. Qiu, Yongxing; Pruitt, John Dallas; Thekveli, Sibichen J.; Tucker, Robert Carey; Nelson, Jared, Silicone hydrogel lenses with water-rich surfaces.
  118. Qiu, Yongxing; Pruitt, John Dallas; Thekveli, Sibichen J.; Tucker, Robert Carey; Nelson, Jared, Silicone hydrogel lenses with water-rich surfaces.
  119. Qiu, Yongxing; Pruitt, John Dallas; Thekveli, Sibichen J.; Tucker, Robert Carey; Nelson, Jared, Silicone hydrogel lenses with water-rich surfaces.
  120. Alt, Eckhard, Stent device and method.
  121. Schense, Jason; Watson, John; Arrighi, Isabelle, Supplemented matrices for the repair of bone fractures.
  122. Hussain, Ali; Cahalan, Linda; Johnson, Greg; Gartner, Mark; Cahalan, Patrick; Fill, Brian J; Speakman, Jeffrey W., Surface treated staples, sutures and dental floss and methods of manufacturing the same.
  123. Trollsas, Mikael; Kleiner, Lothar W.; Hossainy, Syed F. A., Tailored aliphatic polyesters for stent coatings.
  124. Hai Ton That ; Pereira David E. ; Nelson Deanna J., Therapeutic hemoglobin composition having isotropically increased size.
  125. Kunz, Lawrence L.; Anderson, Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
  126. Kunz, Lawrence L.; Anderson, Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
  127. Kunz, Lawrence L.; Anderson, Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
  128. Holme Kevin R. ; Shaklee Patrick N. ; Ishihara Masayuki, Therapeutic methods of using O-desulfated heparin derivatives.
  129. Hsu Li-Chien ; Hu Can B. ; Tong Sun-De, Universal biocompatible coating platform for medical devices.
  130. Marciani, Dante J., Use of imine-forming polysaccharides as adjuvants and immunostimulants.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로